We are leveraging our
knowledge of new autophagy
biology to create new therapeutics
Our Science
The mission of Samsara is to identify new therapeutics for difficult to treat diseases such as rare genetic disease and neurodegenerative disorders. We do that by discovering new molecules that restore or induce the process of cellular autophagy.
Our strategy to identify molecules that influence autophagy is via an unbiased screening approach coupled with techniques that enable us to understand mechanism and target. In this way we are uncovering new biology and ultimately powerful and novel therapeutic agents.
The Lysoseeker™ Platform
A unique approach for discovering new autophagy therapeutics.
Rare Monogenic Disease
What if we could offer real hope for serious rare genetic diseases?
Neurodegeneration
What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?
Our Pipeline
Samsara is leveraging its knowledge of new autophagy biology.
Further Pipeline Expansion
Samsara Therapeutics Receives $3.2 Million Seed Funding for Further Pipeline Expansion.
Autophagy, healthspan and lifespan
Our strategy in Samsara is to treat diseases where there is a high unmet need. But we also want to find out how our molecules work to affect healthspan and longevity.
Introducing Samsara
Over the last twenty years or so, the phenomenon of autophagy has become a hot topic in the world of biology.
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy